Vessel sealing system

Information

  • Patent Grant
  • 7303557
  • Patent Number
    7,303,557
  • Date Filed
    Monday, December 27, 2004
    20 years ago
  • Date Issued
    Tuesday, December 4, 2007
    17 years ago
Abstract
A method for electrosurgically sealing a tissue includes steps of: (A) applying a first pulse of RF energy to the tissue; and (B) applying at least one subsequent RF energy pulse to the tissue and keeping constant or varying RF energy parameters of individual pulses in accordance with at least one characteristic of an electrical transient that occurs during the individual RF energy pulses. The method terminates the generation of subsequent RF pulses upon a determination that the electrical transient has passed a predetermined limit.
Description
FIELD

This invention relates generally to medical instruments and, in particular, to generators that provide radio frequency (RF) energy useful in sealing tissue and vessels during electrosurgical and other procedures.


BACKGROUND

Electrosurgical generators are employed by surgeons to cut and coagulate the tissue of a patient. High frequency electrical power, which may be also referred to as radio frequency (RF) power or energy, is produced by the electrosurgical generator and applied to the tissue by an electrosurgical tool. Both monopolar and bipolar configurations are commonly used during electrosurgical procedures.


Electrosurgical techniques can be used to seal small diameter blood vessels and vascular bundles. Another application of electrosurgical techniques is in tissue welding, wherein two layers of tissue are grasped and clamped together by a suitable electrosurgical tool while the electrosurgical RF energy is applied. The two layers of tissue are then “welded” together.


At this point it is significant to note that the process of coagulating small vessels is fundamentally different than vessel sealing or tissue welding. For the purposes herein the term coagulation can be defined as a process of desiccating tissue wherein the tissue cells are ruptured and dried. Vessel sealing or tissue welding can both be defined as desiccating tissue by the process of liquefying the collagen in the tissue so that it crosslinks and reforms into a fused mass. Thus, the coagulation of small vessels if generally sufficient to close them, however, larger vessels normally need to be sealed to assure permanent closure.


However, and as employed herein, the term “electrosurgical desiccation” is intended to encompass any tissue desiccation procedure, including electrosurgical coagulation, desiccation, vessel sealing, and tissue welding.


One of the problems that can arise from electrosurgical desiccation is undesirable tissue damage due to thermal effects, wherein otherwise healthy tissue surrounding the tissue to which the electrosurgical energy is being applied is thermally damaged by an effect known in the art as “thermal spread”. During the occurrence of thermal spread excess heat from the operative site can be directly conducted to the adjacent tissue, and/or the release of steam from the tissue being treated at the operative site can result in damage to the surrounding tissue.


It can be appreciated that it would be desirable to provide an electrosurgical generator that limited the possibility of the occurrence of thermal spread.


Another problem that can arise with conventional electrosurgical techniques is a buildup of eschar on the electrosurgical tool or instrument. Eschar is a deposit that forms on working surface(s) of the tool, and results from tissue that is electrosurgically desiccated and then charred. One result of the buildup of eschar is a reduction in the effectiveness of the surgical tool. The buildup of eschar on the electrosurgical tool can be reduced if less heat is developed at the operative site.


It has been well established that a measurement of the electrical impedance of tissue provides an indication of the state of desiccation of the tissue, and this observation has been utilized in some electrosurgical generators to automatically terminate the generation of electrosurgical power based on a measurement of tissue impedance.


At least two techniques for determining an optimal amount of desiccation are known by those skilled in this art. One technique sets a threshold impedance, and terminates electrosurgical power when the measured tissue impedance crosses the threshold. A second technique terminates the generation of electrosurgical power based on dynamic variations in the tissue impedance.


A discussion of the dynamic variations of tissue impedance can be found in a publication entitled “Automatically Controlled Bipolar Electrocoagulation”, Neurosurgical Review, 7:2-3, pp. 187-190, 1984, by Vallfors and Bergdahl. FIG. 2 of this publication depicts the impedance as a function of time during the heating of a tissue, and the authors reported that the impedance value of tissue was observed to be near to a minimum value at the moment of coagulation. Based on this observation, the authors suggest a micro-computer technique for monitoring the minimum impedance and subsequently terminating the output power to avoid charring the tissue.


Another publication by the same authors, “Studies on Coagulation and the Development of an Automatic Computerized Bipolar Coagulator”, Journal of Neurosurgery, 75:1, pp. 148-151, July 1991, discusses the impedance behavior of tissue and its application to electrosurgical vessel sealing, and reports that the impedance has a minimum value at the moment of coagulation.


The following U.S. patents are also of interest in this area. U.S. Pat. No. 5,540,684, Hassler, Jr. addresses the problem associated with turning off the RF energy output automatically after the tissue impedance has fallen from a predetermined maximum, subsequently risen from a predetermined minimum and then reached a particular threshold. A storage device records maximum and minimum impedance values, and a circuit determines the threshold. U.S. Pat. No. 5,472,443, Cordis et al., discusses a variation of tissue impedance with temperature, wherein the impedance is shown to fall, and then to rise, as the temperature is increased. FIG. 2 of this patent shows a relatively lower temperature Region A where salts contained in body fluids are believed to dissociate, thereby decreasing the electrical impedance. A relatively next higher temperature Region B is where the water in the tissue boils away, causing the impedance to rise. The next relatively higher temperature Region C is where the tissue becomes charred, which results in a slight lowering of the electrical impedance. U.S. Pat. No. 4,191,188, Belt et al., discloses the use of two timers whose duty cycles are simultaneously and proportionately adjusted so that high frequency signal bursts are constantly centered about the peak power point, regardless of duty cycle variations.


Also of interest is U.S. Pat. No. 5,827,271, Buysse et al., “Energy Delivery System for Vessel Sealing”, which employs a surgical tool capable of grasping a tissue and applying an appropriate amount of closure force to the tissue, and for then conducting electrosurgical energy to the tissue concurrently with the application of the closure force. FIG. 2 of this patent, shown herein as FIG. 1 for depicting the prior art, illustrates a set of power curves which represent the electrosurgical power delivered to the tissue as a function of the tissue impedance. At low impedances, the electrosurgical power is increased by rapidly increasing the output current. The increase in electrosurgical power is terminated when a first impedance breakpoint, labeled as 1, is reached (e.g. <20 ohms). Next, the electrosurgical power is held approximately constant until proteins in the vessels and other tissues have melted. The impedance at which this segment ends varies in accordance with the magnitude of the RMS power. For example, where the maximum RMS power is approximately 125 Watts, the segment (B) ends at about 128 ohms. When a lower power is used (e.g., 75 Watts), the segment (C) may end at an impedance value of 256 ohms. Next, the output power is lowered to less than one half the maximum value, and the lower power delivery is terminated when a second impedance breakpoint is reached (2.048×103 ohms). Alternatives to using the impedance for determining the second breakpoint are the use of I-V phase angle, or the magnitude of the output current.


Based on the foregoing it should be evident that electrosurgery requires the controlled application of RF energy to an operative tissue site. To achieve successful clinical results during surgery, the electrosurgical generator should produce a controlled output RF signal having an amplitude and wave shape that is applied to the tissue within predetermined operating levels. However, problems can arise during electrosurgery when rapid desiccation of tissue occurs resulting in excess RF levels being applied to the tissue. These excess levels produce less than desirable tissue effects, which can increase thermal spread, or can cause tissue charring and may shred and disintegrate tissue. It would be desirable to provide a system with more controlled output to improve vessel sealing and reduce damage to surrounding tissue. The factors that affect vessel sealing include the surgical instrument utilized, as well as the generator for applying RF energy to the instrument jaws. It has been recognized that the gap between the instrument jaws and the pressure of the jaws against the tissue affect tissue sealing because of their impact on current flow. For example, insufficient pressure or an excessive gap will not supply sufficient energy to the tissue and could result in an inadequate seal.


However, it has also been recognized that the application of RF energy also affects the seal. For example, pulsing of RF energy will improve the seal. This is because the tissue loses moisture as it desiccates and by stopping or significantly lowering the output the generator between pulses, this allows some moisture to return to the tissue for the application of next RF pulse. It has also been recognized by the inventors that varying each pulse dependent on certain parameters is also advantageous in providing an improved seal. Thus, it would be advantageous to provide a vessel sealing system which better controls RF energy and which can be varied at the outset of the procedure to accommodate different tissue structures, and which can further be varied during the procedure itself to accommodate changes in the tissue as it desiccates.


An accommodation for overvoltage clamping is also desirable. In this regard, conventional overvoltage techniques use a means of clamping or clipping the excess overvoltage using avalanche devices such as diodes, zener diodes and transorbs so as to limit the operating levels. In these techniques the excess energy, as well as the forward conduction energy, is absorbed by the protection device and inefficiently dissipated in the form of heat. More advanced prior art techniques actively clamp only the excess energy using a predetermined comparator reference value, but still absorb and dissipate the excess energy in the form of heat.


U.S. Pat. No. 5,594,636 discloses a system for AC to AC power conversion using switched commutation. This system addresses overvoltage conditions which occur during switched commutation by incorporating an active output voltage sensing and clamping using an active clamp voltage regulator which energizes to limit the output. The active clamp switches in a resistive load to dissipate the excess energy caused by the overvoltage condition.


Other patents in this area include U.S. Pat. No. 5,500,616, which discloses an overvoltage clamp circuit, and U.S. Pat. No. 5,596,466, which discloses an isolated half-bridge power module. Both of these patents identify output overvoltage limiting for all power devices, and overvoltage limit protection is provided for power devices by using proportionately scaled zeners to monitor and track the output off voltage of each device to prevent power device failure. The zener device is circuit configured such that it provides feedback to the gate of the power device, When zener avalanche occurs the power device partially turns on, absorbing the excess overvoltage energy in conjunction with the connective load.


Reference can also be had to U.S. Pat. No. 4,646,222 for disclosing an inverter incorporating overvoltage clamping. Overvoltage clamping is provided by using diode clamping devices referenced to DC power sources. The DC power sources provide a predetermined reference voltage to clamp the overvoltage condition, absorbing the excess energy through clamp diodes which dissipate the excess voltage in the form of heat.


It would be advantageous as to provide an electrosurgical generator having improved overvoltage limit and transient energy suppression.


SUMMARY

The foregoing and other problems are overcome by methods and apparatus in accordance with embodiments disclosed herein.


An electrosurgical generator includes a controlling data processor that executes software algorithms providing a number of new and useful features. These features preferably include the generation of an initial pulse, that is a low power pulse of RF energy that is used to sense at least one electrical characteristic of the tissue prior to starting an electrosurgical desiccation cycle, such as a tissue sealing cycle. The sensed electrical characteristic is then used as an input into the determination of initial sealing parameters, thereby making the sealing procedure adaptive to the characteristics of the tissue to be sealed. Another feature preferably provided measures the time required for the tissue to begin desiccating, preferably by observing an electrical transient at the beginning of an RF energy pulse, to determine and/or modify further seal parameters. Another preferable feature performs a tissue temperature control function by adjusting the duty cycle of the RF energy pulses applied to the tissue, thereby avoiding the problems that can result from excessive tissue heating. A further preferable feature controllably decreases the RF pulse voltage with each pulse of RF energy so that as the tissue desiccates and shrinks (thereby reducing the spacing between the surgical tool electrodes), arcing between the electrodes is avoided, as is the tissue destruction that may result from uncontrolled arcing. Preferably a Seal Intensity operator control is provided that enables the operator to control the sealing of tissue by varying parameters other than simply the RF power.


The system disclosed herein preferably further provides a unique method for overvoltage limiting and transient energy suppression. An electrosurgical system uses dynamic, real-time automatic detuning of the RF energy delivered to the tissue of interest. More specifically, this technique automatically limits excess output RF voltages by dynamically changing the tuning in a resonant source of RF electrosurgical energy, and by altering the shape of the RF source signal used to develop the output RF signal. The inventive technique limits the excess output transient RF energy by a resonant detuning of the generator. This occurs in a manner which does not clip or significantly distort the generated RF output signal used in a clinical environment for electrosurgical applications.


A method for electrosurgically sealing a tissue, in accordance with this disclosure, preferably includes the steps of (A) applying an initial pulse of RF energy to the tissue, the pulse having characteristics selected so as not to appreciably heat the tissue; (B) measuring a value of at least one electrical characteristic of the tissue in response to the applied first pulse; (C) in accordance with the measured at least one electrical characteristic, determining an initial set of pulse parameters for use during a first RF energy pulse that is applied to the tissue; and (D) varying the pulse parameters of subsequent RF energy pulses individually in accordance with at least one characteristic of an electrical transient that occurs at the beginning of each individual subsequent RF energy pulse. The method terminates the generation of subsequent RF energy pulses based upon a reduction in the output voltage or upon a determination that the electrical transient is absent.


The at least one characteristic that controls the variation of the pulse parameters is preferably a width of the electrical transient that occurs at the beginning of each subsequent RF energy pulse. The initial set of pulse parameters include a magnitude of a starting power and a magnitude of a starting voltage, and the pulse parameters that are varied include a pulse duty cycle and a pulse amplitude. Preferably, the subsequent RF energy pulses are each reduced in amplitude by a controlled amount from a previous RF energy pulse, thereby compensating for a decrease in the spacing between the surgical tool electrodes due to desiccation of the tissue between the electrodes.


The step of determining an initial set of pulse parameters preferably includes a step of using the measured value of at least one electrical characteristic of the tissue to readout the initial set of pulse parameters from an entry in a lookup table.


The step of determining an initial set of pulse parameters may also preferably include a step of reading out the initial set of pulse parameters from an entry in one of a plurality of lookup tables, where the lookup table is selected either manually or automatically, based on the electrosurgical instrument or tool that is being used.


The method also preferably includes a step of modifying predetermined ones of the pulse parameters in accordance with a control input from an operator. The predetermined ones of the pulse parameters that are modified include a pulse power, a pulse starting voltage level, a pulse voltage decay scale factor, and a pulse dwell time.


Preferably a circuit is coupled to the output of the electrosurgical generator for protecting the output against an overvoltage condition, and includes a suppressor that detunes a tuned resonant circuit at the output for reducing a magnitude of a voltage appearing at the output. In accordance with this aspect of the disclosure, the circuit has a capacitance network in parallel with an inductance that forms a portion of the output stage of the generator. A voltage actuated switch, such as a transorb, couples an additional capacitance across the network upon an occurrence of an overvoltage condition, thereby detuning the resonant network and reducing the magnitude of the voltage output.





BRIEF DESCRIPTION OF THE DRAWINGS

The above set forth and other features of the invention are made more apparent in the ensuing Detailed Description when read in conjunction with the attached Drawings, wherein:



FIG. 1A is a graph that plots output power versus tissue impedance (Z) in ohms, in accordance with the operation of a prior art electrosurgical generator;



FIG. 1B is a graph that plots output power versus impedance in ohms, in accordance with the operation of an electrosurgical generator that is an aspect of this disclosure;



FIG. 2 is a simplified block diagram of an electrosurgical system that can be used to practice the teachings of this disclosure;



FIG. 3 is a perspective view of one embodiment of a surgical instrument having bipolar forceps that are suitable for practicing this disclosure;



FIG. 4 is an enlarged, perspective view of a distal end of the bipolar forceps shown in FIG. 3;



FIG. 5 is a perspective view of an embodiment of a surgical instrument having forceps that are suitable for use in an endoscopic surgical procedure utilizing the electrosurgical system disclosed herein;



FIG. 6A is a simplified block diagram of a presently preferred embodiment of the power control circuit of the electrosurgical generator of FIG. 2;



FIG. 6B depicts the organization of a seal parameter lookup table (LUT) shown in FIG. 6A;



FIGS. 7
a and 7b illustrate a presently preferred electrosurgical generator output waveform of RMS current vs. time for implementing at least the first pulse of the pulsed operation mode that is an aspect of this disclosure;



FIG. 8 depicts a full set of electrosurgical RF pulses in accordance with this disclosure, and illustrates the voltage, current and power characteristics of the pulses, as well as the response of the tissue impedance to the applied RF pulses;



FIG. 9A illustrates a Seal Intensity control that forms a part of this disclosure, while FIG. 9B shows a presently preferred variation in certain parameters from the seal parameter LUT based on different Seal Intensity settings;



FIG. 10 is a simplified block diagram of a circuit for achieving an overvoltage limiting and transient energy suppression energy function;



FIG. 11 is a waveform diagram illustrating the effect of the operation of the circuit in FIG. 10;



FIG. 12 is a logic flow diagram that illustrates a method in accordance with the system disclosed herein;



FIG. 13 is a more detailed logic flow diagram that illustrates a method in accordance with the system disclosed herein;



FIG. 14 is a chart illustrating a fixed number of pulses determined from the measured impedance and the RMS current pulse width;



FIG. 15 illustrates a Precise Seal Intensity control that forms a part of this disclosure; and



FIG. 16 is a logic flow diagram that illustrates another method in accordance with the system disclosed herein.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

An electrosurgical system 1, which can be used to practice this invention, is shown in FIG. 2. The system 1 can be used for sealing vessels 3 and other tissues of a patient, including ducts, veins, arteries and vascular tissue. The system 1 includes an electrosurgical generator 2 and a surgical tool, also referred to herein as a surgical instrument 4. The surgical instrument 4 is illustrated by way of example, and as will become apparent from the discussion below, other instruments can be utilized. The electrosurgical generator 2, which is of most interest to the teachings herein, includes several interconnected sub-units, including an RF drive circuit 2A, a power control circuit 2B, a variable D.C. power supply 2C and an output amplifier 2D. The surgical instrument 4 is electrically connected to the electrosurgical generator 2 using a plug 5 for receiving controlled electrosurgical power therefrom The surgical instrument 4 has some type of end effector member 6, such as a forceps or hemostat, capable of grasping and holding the vessels and tissues of the patient. The member 6, also referred to simply as end effector 6, is assumed, in this embodiment, to be capable of applying and maintaining a relatively constant level of pressure on the vessel 3.


The member 6 is provided in the form of bipolar electrosurgical forceps using two generally opposing electrodes disposed on inner opposing surfaces of the member 6, and which are both electrically coupled to the output of the electrosurgical generator 2. During use, different electric potentials are applied to each electrode. In that tissue is an electrical conductor, when the forceps are utilized to clamp or grasp the vessel 3 therebetween, the electrical energy output from the electrosurgical generator 2 is transferred through the intervening tissue. Both open surgical procedures and endoscopic surgical procedures can be performed with suitably adapted surgical instruments 4. It should also be noted that the member 6 could be monopolar forceps that utilize one active electrode, with the other (return) electrode or pad being attached externally to the patient, or a combination of bipolar and monopolar forceps.


By way of further explanation, FIG. 3 is a perspective view of one embodiment of the surgical instrument 4 having a bipolar end effector implemented as forceps 6A while FIG. 4 is an enlarged, perspective view of a distal end of the bipolar forceps 6A shown in FIG. 3.


Referring now to FIGS. 3 and 4, a bipolar surgical instrument 4 for use with open surgical procedures includes a mechanical forceps 20 and an electrode assembly 21. In the drawings and in the description which follows, the term “proximal”, as is traditional, refers to the end of the instrument 4 which is closer to the user, while the term “distal” refers to the end which is further from the user.


Mechanical forceps 20 includes first and second members 9 and 11 which each have an elongated shaft 12 and 14, respectively. Shafts 12 and 14 each include a proximal end and a distal end. Each proximal end of each shaft portion 12, 14 includes a handle member 16 and 18 attached thereto to allow a user to effect movement of the two shaft portions 12 and 14 relative to one another. Extending from the distal end of each shaft portion 12 and 14 are end effectors 22 and 24, respectively. The end effectors 22 and 24 are movable relative to one another in response to movement of handle members 16 and 18. These end effectors members 6A can be referred to collectively as bipolar forceps.


Preferably, shaft portions 12 and 14 are affixed to one another at a point proximate the end effectors 22 and 24 about a pivot 25. As such, movement of the handles 16 and 18 imparts movement of the end effectors 22 and 24 from an open position, wherein the end effectors 22 and 24 are disposed in spaced relation relative to one another, to a clamping or closed position, wherein the end effectors 22 and 24 cooperate to grasp the tubular vessel 3 therebetween. Either one or both of the end effectors 22, 24 can be movable.


As is best seen in FIG. 4, end effector 24 includes an upper or first jaw member 44 which has an inner facing surface and a plurality of mechanical interfaces disposed thereon which are dimensioned to releasable engage a portion of an electrode assembly 21, which may be disposable. Preferably, the mechanical interfaces include sockets 41 which are disposed at least partially through the inner facing surface of jaw member 44 and which are dimensioned to receive a complimentary detent attached to an upper electrode 21A of the disposable electrode assembly 21. The upper electrode 21A is disposed across from a corresponding lower electrode 21B. The end effector 22 includes a second or lower jaw member 42 which has an inner facing surface which opposes the inner facing surface of the first jaw member 44.


Preferably, shaft members 12 and 14 of the mechanical forceps 20 are designed to transmit a particular desired force to the opposing inner facing surfaces of the jaw members 22 and 24 when clamped. In particular, since the shaft members 12 and 14 effectively act together in a spring-like manner (i.e., bending that behaves like a spring), the length, width, height and deflection of the shaft members 12 and 14 directly impacts the overall transmitted force imposed on opposing jaw members 42 and 44. Preferably, jaw members 22 and 24 are more rigid than the shaft members 12 and 14 and the strain energy stored in the shaft members 12 and 14 provides a constant closure force between the jaw members 42 and 44.


Each shaft member 12 and 14 also includes a ratchet portion 32 and 34. Preferably, each ratchet, e.g., 32, extends from the proximal end of its respective shaft member 12 towards the other ratchet 34 in a generally vertically aligned manner such that the inner facing surfaces of each ratchet 32 and 34 abut one another when the end effectors 22 and 24 are moved from the open position to the closed position. Each ratchet 32 and 34 includes a plurality of flanges which project from the inner facing surface of each ratchet 32 and 34 such that the ratchets 32 and 34 can interlock in at least one position. In the embodiment shown in FIG. 3, the ratchets 32 and 34 interlock at several different positions. Preferably, each ratchet position holds a specific, i.e., constant, strain energy in the shaft members 12 and 14 which, in turn, transmits a specific force to the end effectors 22 and 24 and, thus, to the electrodes 21A and 21B. Also, preferably a stop is provided on one or both of the end effectors 22, 24 to maintain a minimum gap between the jaws.


In some cases it may be preferable to include other mechanisms to control and/or limit the movement of the jaw members 42 and 44 relative to one another. For example, a ratchet and pawl system could be utilized to segment the movement of the two handles into discrete units which, in turn, impart discrete movement to the jaw members 42 and 44 relative to one another.



FIG. 5 is a perspective view of an embodiment of the surgical instrument 4 having end effector members or forceps 6B that are suitable for an endoscopic surgical procedure. The end effector member 6B is depicted as sealing the tubular vessel 3 through a cannula assembly 130, 132.


The surgical instrument 4 for use with endoscopic surgical procedures includes a drive rod assembly 50 which is coupled to a handle assembly 54. The drive rod assembly 50 includes an elongated hollow shaft portion 52 having a proximal end and a distal end. An end effector assembly 6B is attached to the distal end of shaft 52 and includes a pair of opposing jaw members. Preferably, handle assembly 54 is attached to the proximal end of shaft 52 and includes an activator 56 for imparting movement of the forceps jaw members of end effector member 6B from an open position, wherein the jaw members are disposed in spaced relation relative to one another, to a clamping or closed position, wherein the jaw members cooperate to grasp tissue therebetween.


Activator 56 includes a movable handle 58 having an aperture 60 defined therein for receiving at least one of the operator's fingers and a fixed handle 62 having an aperture 64 defined therein for receiving an operator's thumb. Movable handle 58 is selectively moveable from a first position relative to fixed handle 62 to a second position in the fixed handle 62 to close the jaw members. Preferably, fixed handle 62 includes a channel 66 which extends proximally for receiving a ratchet 68 which is coupled to movable handle 58. This structure allows for progressive closure of the end effector assembly, as well as a locking engagement of the opposing jaw members. In some cases it may be preferable to include other mechanisms to control and/or limit the movement of handle 58 relative to handle 62 such as, e.g., hydraulic, semi-hydraulic and/or gearing systems. As with instrument 4, a stop can also be provided to maintain a minimum gap between the jaw members.


The handle 62 includes handle sections 62a and 62b, and is generally hollow such that a cavity is formed therein for housing various internal components. For example, the cavity can house a PC board which controls the electrosurgical energy being transmitted from the electrosurgical generator 2 to each jaw member, via connector 5. More particularly, electrosurgical energy generated from the electrosurgical generator 2 is transmitted to the handle PC board by a cable 5A. The PC board converts the electrosurgical energy from the generator into two different electrical potentials which are transmitted to each jaw member by a separate terminal clip. The handle 62 may also house circuitry that communicates with the generator 2, for example, identifying characteristics of the electrosurgical tool 4 for use by the electrosurgical generator 2, where the electrosurgical generator 2 may select a particular seal parameter lookup table based on those characteristics (as described below).


Preferably, a lost motion mechanism is positioned between each of the handle sections 62a and 62b for maintaining a predetermined or maximum clamping force for sealing tissue between the jaw members.


Having thus described two exemplary and non-limiting embodiments of surgical instruments 4 that can be employed with the electrosurgical generator 2, a description will now be provided of various aspects of the inventive electrosurgical generator 2.



FIG. 6A is a block diagram that illustrates the power control circuit 2B of FIG. 2 in greater detail. The power control circuit 2B includes a suitably programmed data processor 70 that is preferably implemented as one or more microcontroller devices. In a most preferred embodiment there are two principal microcontrollers, referred to as a main microcontroller 70A and a feedback microcontroller 70B. These two microcontrollers are capable of communicating using shared data that is stored and retrieved from a shared read/write memory 72. A control program for the data processor 70 is stored in a program memory 74, and includes software routines and algorithms for controlling the overall operation of the electrosurgical generator 2. In general, the feedback microcontroller 70B has a digital output bus coupled to an input of a digital to analog converter (DAC) block 76 which outputs an analog signal. This is a system control voltage (SCV), which is applied to the variable DC power supply 2C to control the magnitude of the voltage and current of output RF pulses.


An analog to digital converter (ADC) block 78 receives analog inputs and sources a digital input bus of the feedback microcontroller 70B. Using the ADC block 78 the microcontroller 70B is apprised of the value of the actual output voltage and the actual output current, thereby closing the feedback loop with the SCV signal. The values of the output voltage and current can be used for determining tissue impedance and for the overall, general control of the applied RF energy waveform. It should be noted that at least the ADC block 78 can be an internal block of the feedback microcontroller 70B, and need not be a separate, external component. It should be further noted that the same analog signals can be digitized and read into the master microcontroller 70A, thereby providing redundancy. The master microcontroller 70A controls the state (on/off) of the high voltage (e.g., 190V max) power supply as a safety precaution, controls the front panel display(s), such as a Seal Intensity display, described below and shown in FIG. 9A, and also receives various input switch closures, such as a Seal Intensity selected by an operator.


It is noted that in a preferred embodiment of the electrosurgical generator 2 a third (waveform) microcontroller 70C is employed to generate the desired 470 kHz sinusoidal waveform that forms the basis of the RF pulses applied to the tissue to be sealed, such as the vessel 3 (FIG. 2). The waveform microcontroller 70C is controlled by the feedback microcontroller 70B and is programmed thereby. An output signal line from the feedback microcontroller 70B is coupled to a Reset input of the waveform microcontroller 70C to essentially turn the waveform microcontroller 70C on and off to provide the pulsed RF signal in accordance with an aspect of this disclosure. This particular arrangement is, of course, not to be viewed in a limiting sense upon the practice of this system, as those skilled in the art may derive a number of methods and circuits for generating the desired RF pulses in accordance with the teachings found herein.


As an overview, the software algorithms executed by the data processor 70 provide the following features. First, and referring now also to the preferred waveform depicted in FIG. 7, a low power initial pulse of RF energy is used to sense at least one electrical characteristic of the tissue prior to starting the seal cycle. Second, the sensed electrical characteristic of the tissue is used as an input into the determination of the initial sealing parameters, thereby making the sealing procedure adaptive to the characteristics of the tissue to be sealed. Third, the technique measures the time required for the tissue to begin desiccating, preferably by observing an electrical transient, to determine and/or modify further seal parameters. Fourth, the technique performs a tissue temperature control function by adjusting the duty cycle of RF pulses applied to the tissue, thereby avoiding excessive tissue heating and the problems that arise from excessive tissue heating. This is preferably accomplished by using at least one calculated seal parameter related to the time required for the tissue to begin desiccating. Fifth, the technique controllably decreases the RF pulse voltage with each pulse of RF energy so that as the tissue desiccates and shrinks (thereby reducing the spacing between the surgical instrument electrodes), arcing between the instrument electrodes (e.g. 21A and 21B of FIG. 4) is avoided, as is the tissue destruction that may result from such uncontrolled arcing. This is also preferably accomplished by using at least one calculated seal parameter that is related to the time required for the tissue to begin desiccating. Sixth, the above-mentioned Seal Intensity front panel control (FIG. 9A) enables the operator to control the sealing of tissue by varying parameters other than simply the RF power. These various aspects of this disclosure are now described in further detail.


Referring now also to the logic flow diagram of FIG. 13, the impedance sensing feature is implemented at the beginning of the seal cycle, wherein the electrosurgical generator 2 senses at least one electrical characteristic of the tissue, for example, impedance, I-V phase rotation, or the output current, by using a short burst of RF energy (FIG. 13, Steps A and B). The electrical characteristic of the tissue may be measured at any frequency or power level, but preferably is performed at the same frequency as the intended working frequency (e.g., 470 kHz). In a most preferred case the short burst of RF energy (preferably less than about 200 millisecond, and more preferably about 100 millisecond) is a 470 kHz sine wave with approximately 5 W of power. The initial pulse RF power is made low, and the pulse time is made as short as possible, to enable an initial tissue electrical characteristic measurement to be made without excessively heating the tissue.


In a most preferred embodiment the electrical characteristic sensed is the tissue impedance which is employed to determine an initial set of parameters that are input to the sealing algorithm, and which are used to control the selection of sealing parameters, including the starting power and voltage (FIG. 13, Step C). Generally, if the sensed impedance is in the lower ranges, then the initial power and starting voltage are made relatively lower, the assumption being that the tissue will desiccate faster and require less energy. If the sensed impedance is in the higher ranges, the initial power and starting voltage are made relatively higher, the assumption being that the tissue will desiccate slower and require more energy.


In other embodiments at least one of any other tissue electrical characteristic, for example, the voltage or current, can be used to set the parameters. These initial parameters are preferably modified in accordance with the setting of the Seal Intensity control input (FIG. 13, Step D), as will be described in further detail below.


Referring again to FIG. 13, Step C, the sensed impedance is employed to determine which set of values are used from a seal parameter lookup table (LUT) 80 (see FIGS. 6A and 6B). The seal parameter look up table may one of a plurality that are stored in the generator or accessible to the generator. Furthermore, the seal parameter table may be selected manually or automatically, based on, for example, the electrosurgical tool or instrument being employed. The specific values read from the seal parameter LUT 80 (FIG. 6B) are then adjusted based on the Seal Intensity front panel setting 82 (FIG. 13, Step D), as is shown more clearly in FIGS. 9A and 9B. In a preferred, but not limiting embodiment, the values read from the seal parameter LUT 80 comprise the power, maximum voltage, starting voltage, minimum voltage, voltage decay, voltage ramp, maximum RF on time, maximum cool scale factor, pulse minimum, pulse dwell time, pulse off time, and the desired pulse width. In a preferred, but not limiting embodiment, the seal parameter values adjusted by the Seal Intensity front panel setting 82 (FIGS. 9A and 9B) comprise the power, starting voltage, voltage decay, and pulse dwell time.



FIG. 1B is a graph that plots output power versus impedance in ohms for the disclosed electrosurgical generator. The plot labeled “Intensity Bar 1” shows the electrosurgical generator power output versus impedance when the “VLOW” setting 82A (FIG. 9A) of the Seal Intensity front panel setting 82 is selected. The plot labeled Intensity Bar 2 shows the power output of the electrosurgical generator when the “LOW” setting 82B of the Seal Intensity front panel setting 82 is selected. The plot labeled Intensity Bars 3, 4, 5, shows the power output of the electrosurgical generator when the “MED” 82C, “HIGH” 82D or VHIGH” 82E Seal Intensity front panel settings 82 are selected. The Seal Intensity front panel settings 82 adjust the seal parameter values as shown in FIG. 9B.


Discussing this aspect of the disclosure now in further detail, and referring as well to FIGS. 7 and 8, the selected Seal Parameter Table, adjusted by the Seal Intensity front panel settings is then utilized by the RF energy generation system and an initial RF sealing pulse is then started.


As each pulse of RF energy is applied to the tissue, the current initially rises to a maximum (Pulse Peak) and then, as the tissue desiccates and the impedance rises due to loss of moisture in the tissue, the current falls, Reference in this regard can be had to the circled areas designated as “A” in the Irms waveform of FIG. 8. The actual width of the resulting electrical transient, preferably a current transient “A”, is an important factor in determining what type and amount of tissue is between the jaws (electrodes) of the surgical instrument 4 (measured from “Full Power RF Start” to “Pulse Low and Stable”.) The actual current transient or pulse width is also employed to determine the changes to, or the values of r the parameters of the pulse duty cycle (“Dwell Time”) and to the reduction of the pulse voltage, as well as other parameters. This parameter can also be used to determine whether the tissue seal has been completed, or if the surgical instrument 4 has shorted.


As an alternative to directly measuring the pulse width, the rate of change of an electrical characteristic (for example current, voltage, impedance, etc.) of the transient “A” (shown in FIG. 7B) may be measured periodically (indicated by the reference number 90 shown in FIG. 7B) over the time the transient occurs. The rate of change of the electrical characteristic may be proportional to the width Δt 95 of the transient “A”, defined by the relationship;

Δt∝de/dt

where de/dt is the change in the electrical characteristic over time. This rate of change may then be used to provide an indication of the width of the transient “A” in determining the type and amount of tissue that is between the jaws (electrodes) of the surgical instrument 4, as well as the subsequent pulse duty cycle (“Dwell Time”), the amount of subsequent pulse voltage reduction, as well as other parameters.


Referring to FIG. 13, Step E, a subsequent RF energy pulse is applied to the tissue, and the pulse width of the leading edge current transient is measured (FIG. 13, Step F). A determination is made if the current transient is present. If it is, control passes via connector “a” to Step H, otherwise control passes via connector “b” to Step K.


Assuming that the current transient is present, and referring to FIG. 13, Step H, if the current transient pulse is wide, for example, approximately in the range of 500-1000 ms, then one can assume the presence of a large amount of tissue, or tissue that requires more RF energy to desiccate. Thus, the Dwell Time is increased, and a small reduction is made in the amplitude of the next RF pulse (see the Vrms waveform in FIG. 8, and FIG. 13, Step I). If the current transient pulse is narrow, for example, about 250 ms or less (indicating that the tissue impedance rapidly rose), then one can assume a small amount of tissue, or a tissue type that requires little RF energy to desiccate is present. Other ranges of current transient pulse widths can also be used. The relationship between the current transient pulse width and the tissue characteristics may be empirically derived. In this case the Dwell Time can be made shorter, and a larger reduction in the amplitude of the next RF pulse can be made as well (FIG. 13, Step J).


If a current pulse is not observed at FIG. 13, Step G, it may be assumed that either the instrument 4 has shorted, the tissue has not yet begun to desiccate, or that the tissue has been fully desiccated and, thus, the seal cycle is complete. The determination of which of the above has occurred is preferably made by observing the tissue impedance at FIG. 13, Steps K and M. If the impedance is less than a low threshold value (THRESHL), then a shorted instrument 4 is assumed (FIG. 13, Step L), while if the impedance is greater than a high threshold value (THRESHH), then a complete tissue seal is assumed (FIG. 13, Step N).


If the tissue impedance is otherwise found to be between the high and low threshold values, a determination is made as to whether the Max RF On Time has been exceeded. If the Max RF On Time has been exceeded, it is assumed that the seal cannot be successfully completed for some reason and the sealing procedure is terminated. If the Max RF On Time has not been exceeded then it is assumed that the tissue has not yet received enough RF energy to start desiccation, and the seal cycle continues (connector “c”).


After the actual pulse width measurement has been completed, the Dwell Time is determined based on the actual pulse width and on the Dwell Time field in the seal parameter LUT 80 (see FIG. 6B.) The RF pulse is continued until the Dwell Time has elapsed, effectively determining the total time that RF energy is delivered for that pulse. The RF pulse is then reduced to a very low level (effectively off) for an amount of time specified by the Pulse Off field. This low level allows some moisture to return to the tissue.


Based on the initial Desired Pulse Width field of the seal parameter LUT 80 for the first pulse, or, for subsequent pulses, the actual pulse width of the previous pulse, the desired voltage limit is raised or lowered based on the Voltage Decay and Voltage Ramp fields. The desired voltage limit is raised during the pulse if the actual pulse widen is greater than the Desired Pulse Width field (or last actual pulse width), and is lowered if the actual pulse width is less than the Desired Pulse Width field (or the last actual pulse width).


When the Desired Voltage has been reduced to the Minimum Voltage field, then the RF energy pulsing is terminated and the electrosurgical generator 2 enters a cool-down period having a duration that is set by the Maximum Cool SF field and the actual pulse width of the first pulse.


Several of the foregoing and other terms are defined with greater specificity as follows (see also FIG. 7).


The Actual Pulse width is the time from pulse start to pulse low. The Pulse Peak is the point where the current reaches a maximum value, and does not exceed this value for some predetermined period of time (measured in milliseconds). The peak value of the Pulse Peak can be reached until the Pulse Peak-X % value is reached, which is the point where the current has decreased to some predetermined determined percentage, X, of the value of Pulse Peak. Pulse Low is the point where the current reaches a low point, and does not go lower for another predetermined period of time. The value of the Maximum RF On Time or MAX Pulse Time is preferably preprogrammed to some value that cannot be readily changed. The RF pulse is terminated automatically if the Pulse Peak is reached but the Pulse Peak-X % value is not obtained with the duration set by the Maximum RF On Time field of the seal parameter LUT 80.


Referring to FIG. 6B, the seal parameter LUT 80 is employed by the feedback microcontroller 10B in determining how to set the various outputs that impact the RF output of the electrosurgical generator 2. The seal parameter LUT 80 is partitioned into a plurality of storage regions, each being associated with a particular measured initial impedance. More particularly, the Impedance Range defines a plurality of impedance breakpoints (in ohms) which are employed to determine which set of variables are to be used for a particular sealing cycle. The particular Impedance Range that is selected is based on the above described Impedance Sense State (FIG. 7) that is executed at the start of the seal cycle. The individual data fields of the seal parameter LUT 80 are defined as follows.


The actual values for the Impedance Ranges of Low, Med Low, Med High, or High, are preferably contained in one of a plurality of tables stored in the generator 2, or otherwise accessible to the generator 2. A specific table may be selected automatically, for example, based on signals received from the electrosurgical tool 4 being used, or by the operator indicating what electrosurgical tool is in use.


Power is the RF power setting to be used (in Watts). Max Voltage is the greatest value that the output voltage can achieve (e.g., range 0-about 190V). Start Voltage is the greatest value that the first pulse voltage can achieve (e.g., range 0-about 190V). Subsequent pulse voltage values are modified downwards from this value. The Minimum Voltage is, the voltage endpoint, and the seal cycle can be assumed to be complete when the RF pulse voltage has been reduced to this value. The Voltage Decay scale factor is the rate (in volts) at which the desired voltage is lowered if the current Actual Pulse Width is less than the Desired Pulse Width. The Voltage Ramp scale factor is the rate at which the desired voltage will be increased if the Actual Pulse Width is greater than the Desired Pulse Width. The Maximum RF On Time is the maximum amount of time (e.g., about one second) that the RF power can be delivered, as described above. The Maximum Cool Down Time determines the generator cool down time, also as described above. Pulse Minimum establishes the minimum Desired Pulse Width value. It can be noted that for each RF pulse, the Desired Pulse Width is equal to the Actual Pulse Width from the previous pulse, or the Desired Pulse field if the first pulse. The Dwell Time scale factor was also discussed previously, and is the time (in milliseconds) that the RF pulse is continued after the current drops to the Pulse Low and Stable point (see FIG. 7). Pulse Off is the off time (in milliseconds) between RF pulses. Desired Pulse Width is a targeted pulse width and determines when the Desired Voltage (Vset) is raised or lowered. If the Actual Pulse Width is less than the Desired Pulse Width, then Vset is decreased, while if the Actual Pulse Width is greater than the Desired Pulse Width, then Vset is increased. The Desired Pulse Width is a value for the first pulse, when the Actual Pulse Width is used as the Desired Pulse Width for each sequential pulse. In general, a new Desired Pulse Width cannot be greater than a previous Desired Pulse Width, and cannot be less than Pulse Minimum.


By applying the series of RF pulses to the tissue, the surgical generator 2 effectively raises the tissue temperature to a certain level, and then maintains the temperature relatively constant. If the RF pulse width is too long, then the tissue may be excessively heated and may stick to the electrodes 21A, 21B of the surgical instrument 4, and/or an explosive vaporization of tissue fluid may damage the tissue, such as the vessel 3. If the RF pulse width is too narrow, then the tissue will not reach a temperature that is high enough to properly seal. As such, it can be appreciated that a proper balance of duty cycle to tissue type is important.


During the pulse off cycle that is made possible in accordance with the teachings herein, the tissue relaxes, thereby allowing the steam to exit without tissue destruction. The tissue responds by rehydrating, which in turn lowers the tissue impedance. The lower impedance allows the delivery of more current in the next pulse. This type of pulsed operation thus tends to regulate the tissue temperature so that the temperature does not rise to an undesirable level, while still performing the desired electrosurgical procedure, and may also allow more energy to be delivered, and thus achieving better desiccation.


As each RF pulse is delivered to the tissue, the tissue desiccates and shrinks due to pressure being applied by the jaws of the surgical instrument 4. The inventors have realized that if the voltage applied to the tissue is not reduced, then as the spacing between the jaws of the surgical instrument 4 is gradually reduced due to shrinking of the tissue, an undesirable arcing can develop which may vaporize the tissue, resulting in bleeding.


As is made evident in the Vrms trace of FIG. 8, and as was described above, the voltage of each successive RF pulse can be controllably decreased, thereby compensating for the desiccation-induced narrowing of the gap between the surgical instrument electrodes 21A and 21B. That is, the difference in electric potential between the electrodes is decreased as the gap between the electrodes decreases, thereby avoiding arcing.


As was noted previously, the Seal Intensity front panel adjustment is not a simple RF power control. The adjustment of the seal intensity is accomplished by adjusting the power of the electrosurgical generator 2, as well as the generator voltage, the duty cycle of the RF pulses, the length of time of the seal cycle (e.g., number of RF pulses), and the rate of voltage reduction for successive RF pulses. FIG. 9B illustrates an exemplary set of parameters (Power, Start Voltage, Voltage Decay and Dwell Time), and how they modify the contents of the seal parameter LUT 80 depending on the setting of the Seal Intensity control 82 shown in FIG. 9A. Generally, higher settings of the Seal Intensity control 82 increase the seal time and the energy delivered while lower settings decrease the seal time and the energy delivered.


It is instructive to note that for the Medium, High and Very High Seal Intensity settings the RF Power remains unchanged, while variations are made instead in the Start Voltage, Voltage Decay and Dwell Time parameters.


Based on the foregoing it can be appreciated that an aspect of this disclosure is a method for electrosurgically sealing a tissue. Referring to FIG. 12, the method includes steps of: (A) applying an initial pulse of RF energy to the tissue, the pulse having characteristics selected so as not to appreciably heat the tissue; (B) measuring at least one electrical characteristic of the tissue in response to the applied-pulse; (C) in accordance with the measured electrical characteristic, determining an initial set of pulse parameters for use during a first RF energy pulse that is applied to the tissue; and (D) varying the pulse parameters of individual ones of subsequent RF energy pulses in accordance with at least one characteristic of an electric current transient that occurs at the beginning of each individual one (pulses) of the subsequent RF energy pulses. The method can terminate the generation of subsequent RF energy pulses upon a determination that the current transient is absent or that the voltage has been reduced to a predefined level.


Reference is now made to FIGS. 10 and 11 for a description of a novel over-voltage limit and transient energy suppression aspect of the system disclosed herein.


A bi-directional transorb TS1 normally is non-operational. As long as the operating RF output levels stay below the turn-on threshold of TS1, electrosurgical energy is provided at a controlled rate of tissue desiccation. However, in the event that rapid tissue desiccation occurs, or that arcing is present in the surgical tissue field, the RF output may exhibit operating voltage levels in excess of the normal RF levels used to achieve the controlled rate of tissue desiccation. If the excess voltage present is left unrestrained, the tissue 3 may begin to exhibit undesirable clinical effects contrary to the desired clinical outcome. The TS1 is a strategic threshold that is set to turn on above normal operating levels, but below and just prior to the RF output reaching an excess voltage level where undesirable tissue effects begin to occur. The voltage applied across TS1 is proportionately scaled to follow the RF output voltage delivered to the tissue 3. The transorb TS1 is selected such that its turn on response is faster than the generator source RF signal. This allows the transorb TS1 to automatically track and respond quickly in the first cycle of an excess RF output overvoltage condition.


Note should be made in FIG. 10 of the capacitor components or network C2, C3, and C4 that parallel the magnetic drive network (MDN1) which has an inductive characteristic and is contained within the electrosurgical generator 2. The combination of the inductive MDN1 and the capacitive networks forms a resonant tuned network which yields the waveshape configuration of the RF source signal shown in FIG. 11.


A turn on of transorb device TS1, which functions as a voltage controlled switch, instantaneously connects the serial capacitance C1 across the capacitor network C2, C3, and C4. An immediate change then appears in the tuning of the resonant network mentioned above, which then instantaneously alters the waveshape of the RF source signal shown in FIG. 11. The time base T1 of the nominally half-sine signal shown increases incrementally in width out to time T2, which automatically lowers the peak voltage of the RF output signal. The peak voltage decreases because the Voltage-Time product of the signal shown in FIG. 11 is constant for a given operating quiescence. The concept of a Voltage-Time product is well known to those skilled in the art, and is not further discussed herein.


As the peak voltage decreases, the excess overvoltage is automatically limited and is restricted to operating levels below that which cause negative clinical effects. Once the excess RF output voltage level falls below the transorb threshold, the TS1 device turns off and the electrosurgical generator 2 returns to a controlled rate of tissue desiccation.


In the event that arcing is present in the surgical tissue field, undesirable excess transient RF energy may exist and may be reflected in the RF output of the electrosurgical generator 2. This in turn may generate a corresponding excess RF output voltage that creates sufficient transient overvoltage to turn on the transorb TS1. In this condition the cycle repeats as described above, where TS1 turns on, alters the resonant tuned network comprised of the magnetic and capacitive components, and thus also alters the RF source signal waveshape. This automatically reduces the excess overvoltage.


In accordance with this aspect of the disclosure, the excess RF transient energy is suppressed and the overvoltage is limited by the dynamic, real-time automatic detuning of the RF energy delivered to the tissue being treated.


It should be noted that the embodiment of FIGS. 10 and 11 can be used to improve the operation of conventional electrosurgical generators, as well as with the novel pulsed output electrosurgical generator 2 that was described previously.


In an additional embodiment the measured electrical characteristic of the tissue, preferably the impedance (Zi), and the RMS current pulse width (PW) may be used to determine a fixed voltage reduction factor (Vdec) to be used for subsequent pulses, and to determine a fixed number of pulses (P#) to be delivered for the sealing procedure. The relationship among the voltage reduction factor, the measured impedance and the RMS current pulse width may be defined as Vdec=F(ZI, PW), and the relationship among the number of pulses, the measured impedance and the RMS current pulse width may be defined as P#=F′ (ZI, PW). In FIG. 14 a fixed number of pulses, P#, 100 determined from the measured impedance and the RMS current pulse width are shown. Each subsequent pulse is reduced by the fixed voltage reduction factor (Vdec) 110, also determined from the measured impedance and the RMS current pulse width.


In a further additional embodiment, tissue sealing is accomplished by the electrosurgical system described above by continuously monitoring or sensing the tissue impedance rate of change. If the rate of change increases above a predetermined limit, then RF pulsing is automatically terminated by controlling the electrosurgical generator 2 accordingly and any previously changed pulse parameters (e.g., power, voltage and current increments) are reset to the original default values. In this embodiment, the ending tissue impedance, i.e., the tissue impedance at the end of each RF pulse, is also continuously monitored or sensed. The ending tissue impedance is then used to determine the pulse parameters for the subsequent RF pulse; to determine if the seal cycle should end (based on the ending impedance of the last few RF pulses which did not change by more than a predetermined amount); and to determine the duty cycle of the subsequent RF pulse.


Further, in this embodiment, RF power, current and/or voltage levels of subsequent RF pulses can be modified on a pulse-by-pulse basis depending on whether the tissue has responded to the previously applied RF energy or pulse (i.e., if the tissue impedance has begun to rise). For example, if the tissue has not responded to a previously applied RF pulse, the RF power output, current and/or voltage levels are increased for the subsequent RF pulse.


Hence, since these RF pulse parameters can subsequently be modified following the initial RF pulse, the initial set of RF pulse parameters, i.e., a magnitude of a starting RF power level, a magnitude of a starting voltage level, and a magnitude of a starting current level, are selected accordingly such that the first or initial RF pulse does not appreciably heat the tissue. One or more of these starting levels are modified during subsequent RF pulses if the tissue has not responded to the previously applied RF pulse which includes the initial RF pulse.


The above functions are implemented by a seal intensity algorithm represented as a set of programmable instructions configured for being executed by at least one processing unit of a vessel sealing system. The vessel sealing system includes a Precise Seal Intensity control panel for manually adjusting the starting voltage level, in a similar fashion as described above with reference to FIGS. 9A and 9B.


As shown in FIG. 15, a preferred Seal Intensity control panel of the present inventive embodiment includes six settings, i.e., “Off” 150A, “VLOW” 150B, “LOW” 150C, “MED” 150D, “HIGH” 150E and “VHIGH” 150F. The Seal Intensity front panel settings 150 adjust the seal parameter values of the Seal Parameter Table as shown by FIGS. 9B and 9C. The selected Seal Parameter Table, adjusted by the Seal Intensity front panel settings 150 is then utilized by an RF generation system, as described above, and an initial RF sealing pulse is then started.


The Seal Intensity front panel settings, as shown in FIGS. 9B and 9C, represent approximate parametric values of several preferred embodiments, identified as an example to achieve vessel sealing performance in clinical procedures. The variety of tissue types and surgical procedures requires the use of one or more Seal Intensity front panel settings.



FIG. 16 is a logic flow diagram that illustrates a method in accordance with the vessel sealing system. At step A′, a RF pulse is applied to tissue. At step B′, the current or tissue impedance rate of change is continuously monitored. At step C′, a determination is made whether the tissue impedance rate of change has passed a predetermined limit, if yes, at step D′, RF pulsing is terminated and any previously changed pulse parameters are reset back to the original defaults. If no, the process proceeds to step E′.


At step E′, a determination is made as to whether the RF pulse has ended. If no, the process loops back to step B′. If yes, the process proceeds to step F′. At step F′, the ending current or tissue impedance is measured. At step G′, the measured ending values are used for determining if the seal cycle should end (based on the current level or ending impedance of the last few RF pulses which did not change by more than a predetermined amount). If yes, the process terminates at step H′. If no, the process continues at step I′, where the ending values are used for determining the pulse parameters, i.e., the power, pulse width, current and/or voltage levels, and the duty cycle of the subsequent RF pulse from an entry in one of a plurality of lookup tables. The process then loops back to step A′. One of the plurality of lookup tables is selected manually or automatically, based on a choice of an electrosurgical tool or instrument.


The process then loops back to step A′. One of the plurality of lookup tables is selected manually or automatically, based on a choice of an electrosurgical tool or instrument.


While the system has been particularly shown and described with respect to preferred embodiments thereof, it will be understood by those skilled in the art that changes in form and details may be made therein without departing from its scope and spirit.

Claims
  • 1. A system for electrosurgically sealing tissue, comprising an electrosurgical generator comprising an RF energy source and a controller for controlling the operation of an electrosurgical generator, said electrosurgical generator having an output for coupling to a surgical instrument comprising electrodes for coupling RF energy generated by said electrosurgical generator to tissue to be sealed; said controller being operable for causing said electrosurgical generator to apply an initial pulse of RF energy to the tissue and for measuring a value of an electrical characteristic of the tissue in response to the applied initial pulse, said controller being responsive to the measured electrical characteristic for determining an initial set of pulse parameters for at least one subsequent pulse and for then controlling the pulse parameters of individual pulses of further subsequent RF energy pulses in accordance with a change in the electrical characteristic of the tissue as determined from at least one characteristic of an electrical transient that occurs during at least one RF energy pulse.
  • 2. A system as in claim 1, wherein the electrical characteristic is comprised of an electrical impedance.
  • 3. A system as in claim 1, wherein the at least one characteristic of the electrical transient is the rate of change of the electrical transient.
  • 4. A system as in claim 1, wherein said initial set of pulse parameter comprise a magnitude of starting power and a magnitude of a starting voltage.
  • 5. A system as in claim 1, wherein said subsequent RF energy pulses are each varied in amplitude by a controlled amount from a previous RF energy pulse.
  • 6. A system as in claim 1, further comprising one of a plurality of pulse parameter lookup tables that is readably coupled to said controller, and wherein said controller, when determining said initial set of pulse parameters, uses said impedance value to readout said initial set of pulse parameters from said one of the plurality of pulse parameter lookup tables.
  • 7. A system as in claim 6, wherein said one of a plurality of pulse parameter lookup tables is selected manually or automatically, based on a choice of an electrosurgical tool or instrument.
  • 8. A system as in claim 1, wherein said controller is responsive to a control input from an operator for modifying any one of said pulse parameters.
  • 9. A system as in claim 1, wherein said controller is responsive to a determination that said electrical transient is absent for terminating a generation of subsequent RF energy pulses.
  • 10. A system for electrosurgically sealing tissue comprising: means for applying a first pulse of RF energy to the tissue;means for measuring at least one electrical characteristic of the tissue in response to the applied first pulse of RF energy; andmeans for applying at least one subsequent RF energy pulse to the tissue and controlling RF energy parameters of individual pulses of further subsequent individual RF energy pulses in accordance with at least one characteristic of an electrical current transient that occurs during the individual RF energy pulses, said RF energy parameters of said at least one subsequent RF energy pulse being controlled according to the at least one measured electrical characteristic of the tissue in response to the applied first pulse of RF energy, wherein said means for applying at least one subsequent RF energy pulse to the tissue and controlling RF energy parameters of individual pulses of further subsequent individual RF energy pulses allows said system to electrosurgically seal tissue without measuring tissue impedance.
  • 11. A system as in claim 10, wherein the means for applying the first pulse includes means for selecting characteristics of the first pulse so as not to excessively heat the tissue.
  • 12. A system as in claim 10, wherein the means for applying the first pulse comprises: means for continuously measuring at least one characteristic of a response of the tissue to the applied first pulse; andmeans for determining whether to change a set of RF energy parameters, in accordance with the measured characteristic.
  • 13. A system as in claim 12, further comprising a default set of RF energy parameters selected from the group consisting of a magnitude of a starting power, a magnitude of a starting voltage, a magnitude of a starting current, and pulse width.
  • 14. A system as in claim 10, wherein the at least one characteristic is selected from the group consisting of a current value, a voltage value, a current phase angle, and a tissue impedance value.
  • 15. A system as in claim 10, wherein the RF energy parameters that are controlled for individual pulses of the RF energy pulses are selected from the group consisting of RF power output, current, voltage, pulse width and duty cycle.
  • 16. A system as in claim 10, further comprising means for determining if the tissue responded to the first pulse of RF energy prior to activating the means for applying at least one subsequent RF energy pulse.
  • 17. A system as in claim 16, wherein the means for applying at least one subsequent RF energy pulse includes means for varying at least one of RF starting power, a magnitude of starting current, pulse width, and a magnitude of starting voltage for the at least one subsequent RF energy pulse.
  • 18. A system as in claim 10, further comprising: means for measuring the at least one characteristic of the electrical current transient that occurs at the end of the first pulse and subsequent RF energy pulses;means for determining whether to terminate the system for electrosurgically sealing tissue, in accordance with the measured characteristic; andmeans for using the measured characteristic to determine a set of RF energy parameters for a subsequent RF energy pulse if the means for determining determines not to terminate the system for electrosurgically sealing tissue.
  • 19. A system as in claim 18, wherein the set of RF energy parameters for the subsequent RF energy pulse comprise a magnitude of a starting RF power, a magnitude of a starting current, a magnitude of a starting pulse width, a magnitude of a starting voltage, and a duty cycle.
  • 20. A system as in claim 18, wherein the means for using the measured characteristic to determine the set of RF energy parameters for the subsequent RF energy pulse comprises means for using the measured at least one characteristic to readout the set of RF energy parameters from an entry in one of a plurality of lookup tables.
  • 21. A system as in claim 20, wherein said one of the plurality of lookup tables is selected manually or automatically, based on a choice of an electrosurgical tool or instrument.
  • 22. A system as in claim 12, further comprising means for modifying predetermined parameters of the set of RF energy parameters in accordance with a control input from an operator.
  • 23. A system as in claim 10, further comprising means for combining an RF energy pulse with at least one subsequent RF energy pulse.
  • 24. A system as in claim 10, further comprising means for terminating a generation of subsequent RF energy pulses upon a determination that the electrical current transient is absent.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation application of application Ser. No. 10/761,524 filed Jan. 21, 2004, the contents of which are hereby incorporated by reference, which is a continuation application of application Ser. No. 10/073,761 filed Feb. 11, 2002, now U.S. Pat. No. 6,796,981. the contents of which are hereby incorporated by reference, which is continuation-in-part application of application Ser. No. 09/408,944, filed Sep. 30, 1999, now U.S. Pat. No. 6,398,779. the contents of which are hereby incorporated by reference, which claims the benefit of U.S. Provisional Application No. 60/105,417, filed Oct. 23, 1998 the contents of which are hereby incorporated by reference.

US Referenced Citations (509)
Number Name Date Kind
1787709 Wappler Jan 1931 A
1813902 Bovie Jul 1931 A
1841968 Lowry Jan 1932 A
1863118 Liebel Jun 1932 A
1945867 Rawls Feb 1934 A
2827056 Degelman Mar 1958 A
2849611 Adams Aug 1958 A
2982881 Reich May 1961 A
3058470 Seeliger et al. Oct 1962 A
3089496 Degelman May 1963 A
3163165 Islikawa Dec 1964 A
3252052 Nash May 1966 A
3391351 Trent Jul 1968 A
3402326 Guasco et al. Sep 1968 A
3413480 Biard et al. Nov 1968 A
3436563 Regitz Apr 1969 A
3439253 Piteo Apr 1969 A
3439680 Thomas, Jr. Apr 1969 A
3461874 Martinez Aug 1969 A
3471770 Haire Oct 1969 A
3478744 Leiter Nov 1969 A
3486115 Anderson Dec 1969 A
3495584 Schwalm Feb 1970 A
3513353 Lansch May 1970 A
3514689 Giannamore May 1970 A
3515943 Warrington Jun 1970 A
3551786 Van Gulik Dec 1970 A
3562623 Farnsworth Feb 1971 A
3571644 Jakoubovitch Mar 1971 A
3589363 Banko Jun 1971 A
3595221 Blackett Jul 1971 A
3601126 Estes Aug 1971 A
3611053 Rowell Oct 1971 A
3641422 Farnsworth et al. Feb 1972 A
3662151 Haffey May 1972 A
3675655 Sittner Jul 1972 A
3683923 Anderson Aug 1972 A
3693613 Kelman Sep 1972 A
3697808 Lee Oct 1972 A
3699967 Anderson Oct 1972 A
3720896 Bierlein Mar 1973 A
3743918 Maitre Jul 1973 A
3766434 Sherman Oct 1973 A
3768482 Shaw Oct 1973 A
3783340 Becker Jan 1974 A
3784842 Kremer Jan 1974 A
3801766 Morrison, Jr. Apr 1974 A
3801800 Newton Apr 1974 A
3812858 Oringer May 1974 A
3815015 Swin et al. Jun 1974 A
3826263 Cage et al. Jul 1974 A
3828768 Douglas Aug 1974 A
3848600 Patrick, Jr. et al. Nov 1974 A
3870047 Gonser Mar 1975 A
3875945 Friedman Apr 1975 A
3885569 Judson May 1975 A
3897787 Ikuno et al. Aug 1975 A
3897788 Newton Aug 1975 A
3901216 Felger Aug 1975 A
3905373 Gonser Sep 1975 A
3913583 Bross Oct 1975 A
3923063 Andrews et al. Dec 1975 A
3933157 Bjurwill et al. Jan 1976 A
3946738 Newton et al. Mar 1976 A
3952748 Kaliher et al. Apr 1976 A
3963030 Newton Jun 1976 A
3964487 Judson Jun 1976 A
3971365 Smith Jul 1976 A
3980085 Ikuno Sep 1976 A
4005714 Hiltebrandt Feb 1977 A
4024467 Andrews et al. May 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4051855 Schneiderman Oct 1977 A
4063557 Wuchinich et al. Dec 1977 A
4074719 Semm Feb 1978 A
4092986 Schneiderman Jun 1978 A
4094320 Newton et al. Jun 1978 A
4102341 Ikuno et al. Jul 1978 A
4114623 Meinke et al. Sep 1978 A
4121590 Gonser Oct 1978 A
4123673 Gonser Oct 1978 A
4126137 Archibald Nov 1978 A
4145636 Doi Mar 1979 A
4171700 Farin Oct 1979 A
4188927 Harris Feb 1980 A
4191188 Belt et al. Mar 1980 A
4196734 Harris Apr 1980 A
4200104 Harris Apr 1980 A
4200105 Gonser Apr 1980 A
4209018 Meinke et al. Jun 1980 A
4231372 Newton Nov 1980 A
4232676 Herczog Nov 1980 A
4237887 Gonser Dec 1980 A
4237891 DuBose et al. Dec 1980 A
4281373 Mabille Jul 1981 A
4287557 Brehse Sep 1981 A
4303073 Archibald Dec 1981 A
4311154 Sterzer et al. Jan 1982 A
4314559 Allen Feb 1982 A
4321926 Roge Mar 1982 A
4334539 Childs et al. Jun 1982 A
4343308 Gross Aug 1982 A
4372315 Shapiro et al. Feb 1983 A
4376263 Pittroff et al. Mar 1983 A
4378801 Oosten Apr 1983 A
4384582 Watt May 1983 A
4397314 Vaguine Aug 1983 A
4407272 Yamaguchi Oct 1983 A
4411266 Cosman Oct 1983 A
4416276 Newton et al. Nov 1983 A
4416277 Newton et al. Nov 1983 A
4429694 McGreevy Feb 1984 A
4437464 Crow Mar 1984 A
4438766 Bowers Mar 1984 A
4452546 Hiltebrandt et al. Jun 1984 A
4463759 Garito et al. Aug 1984 A
4470414 Imagawa et al. Sep 1984 A
4472661 Culver Sep 1984 A
4474179 Koch Oct 1984 A
4492231 Auth Jan 1985 A
4492832 Taylor Jan 1985 A
4494541 Archibald Jan 1985 A
4514619 Kugelman Apr 1985 A
4520818 Mickiewicz Jun 1985 A
4559943 Bowers Dec 1985 A
4565200 Cosman Jan 1986 A
4566454 Mehl et al. Jan 1986 A
4569345 Manes Feb 1986 A
4576177 Webster, Jr. Mar 1986 A
4582057 Auth et al. Apr 1986 A
4590934 Malis et al. May 1986 A
4608977 Brown Sep 1986 A
4630218 Hurley Dec 1986 A
4632109 Patterson Dec 1986 A
4644955 Mioduski Feb 1987 A
4646222 Okado et al. Feb 1987 A
4651264 Shiao-Chung Hu Mar 1987 A
4651280 Chang et al. Mar 1987 A
4657015 Irnich Apr 1987 A
4658815 Farin et al. Apr 1987 A
4658819 Harris et al. Apr 1987 A
4658820 Klicek Apr 1987 A
4662383 Sogawa et al. May 1987 A
4712559 Turner Dec 1987 A
4727874 Bowers et al. Mar 1988 A
4735204 Sussman et al. Apr 1988 A
4739759 Rexroth et al. Apr 1988 A
4741334 Irnich May 1988 A
4754757 Feucht Jul 1988 A
4788634 Schlecht et al. Nov 1988 A
4805621 Heinze et al. Feb 1989 A
4818954 Flachenecker et al. Apr 1989 A
4827911 Broadwin et al. May 1989 A
4827927 Newton May 1989 A
4832024 Boussignac et al. May 1989 A
4848335 Manes Jul 1989 A
4848355 Nakamura et al. Jul 1989 A
4860745 Farin et al. Aug 1989 A
4862889 Feucht Sep 1989 A
4880719 Murofushi et al. Nov 1989 A
4890610 Kirwan et al. Jan 1990 A
4903696 Stasz et al. Feb 1990 A
4907589 Cosman Mar 1990 A
4922210 Flachenecker et al. May 1990 A
4931047 Broadwin et al. Jun 1990 A
4931717 Gray et al. Jun 1990 A
4938761 Ensslin Jul 1990 A
4942313 Kinzel Jul 1990 A
4961047 Carder Oct 1990 A
4961435 Kitagawa et al. Oct 1990 A
4966597 Cosman Oct 1990 A
RE33420 Sussman Nov 1990 E
4969885 Farin Nov 1990 A
4993430 Shimoyama et al. Feb 1991 A
4995877 Ams et al. Feb 1991 A
5015227 Broadwin et al. May 1991 A
5019176 Brandhorst, Jr. May 1991 A
5029588 Yock et al. Jul 1991 A
5087257 Farin Feb 1992 A
5103804 Abele et al. Apr 1992 A
5108389 Cosmescu Apr 1992 A
5108391 Flachenecker Apr 1992 A
5122137 Lennox Jun 1992 A
5133711 Hagen Jul 1992 A
5151102 Kamlyama et al. Sep 1992 A
5152762 McElhenney Oct 1992 A
5157603 Scheller et al. Oct 1992 A
5160334 Billings et al. Nov 1992 A
5162217 Hartman Nov 1992 A
5167658 Ensslin Dec 1992 A
5190517 Zieve et al. Mar 1993 A
5196008 Kuenecke Mar 1993 A
5196009 Kirwan, Jr. Mar 1993 A
5201900 Nardella Apr 1993 A
5207691 Nardella May 1993 A
5230623 Guthrie et al. Jul 1993 A
5233515 Cosman Aug 1993 A
5249121 Baum et al. Sep 1993 A
RE34432 Bertrand Nov 1993 E
5267994 Gentelia et al. Dec 1993 A
5267997 Farin Dec 1993 A
5281213 Milder et al. Jan 1994 A
5300068 Rosar et al. Apr 1994 A
5300070 Gentelia Apr 1994 A
5318563 Malis et al. Jun 1994 A
5323778 Kandarpa et al. Jun 1994 A
5324283 Heckele Jun 1994 A
5330518 Neilson et al. Jul 1994 A
5334193 Nardella Aug 1994 A
5341807 Nardella Aug 1994 A
5342356 Ellman Aug 1994 A
5342357 Nardella Aug 1994 A
5342409 Mullett Aug 1994 A
5348554 Imran et al. Sep 1994 A
5370645 Klicek et al. Dec 1994 A
5370672 Fowler et al. Dec 1994 A
5370675 Edwards et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5383874 Jackson Jan 1995 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5396062 Eisentraut et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5403311 Abele et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5409000 Imran Apr 1995 A
5409006 Buchholtz et al. Apr 1995 A
5409485 Suda Apr 1995 A
5413573 Koivukangas May 1995 A
5414238 Steigerwald et al. May 1995 A
5417719 Hull et al. May 1995 A
5422567 Matsunaga Jun 1995 A
5423808 Edwards et al. Jun 1995 A
5423809 Klicek Jun 1995 A
5423810 Goble et al. Jun 1995 A
5430434 Lederer et al. Jul 1995 A
5432459 Thompson Jul 1995 A
5433739 Sluijter et al. Jul 1995 A
5434398 Goldberg Jul 1995 A
5436566 Thompson Jul 1995 A
5438302 Goble Aug 1995 A
5443463 Stern et al. Aug 1995 A
5445635 Denen Aug 1995 A
5451224 Goble et al. Sep 1995 A
5458597 Edwards et al. Oct 1995 A
5462521 Brucker et al. Oct 1995 A
5472441 Edwards et al. Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5478303 Folry-Nolan et al. Dec 1995 A
5480399 Hebborn Jan 1996 A
5483952 Aranyi Jan 1996 A
5490850 Ellman et al. Feb 1996 A
5496312 Klicek Mar 1996 A
5496313 Gentelia et al. Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5500616 Ochi Mar 1996 A
5514129 Smith May 1996 A
5520684 Imran May 1996 A
5531774 Schulman et al. Jul 1996 A
5534018 Wahlstrand et al. Jul 1996 A
5536267 Edwards et al. Jul 1996 A
5540681 Strul et al. Jul 1996 A
5540683 Ichikawa Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540724 Cox Jul 1996 A
5556396 Cohen et al. Sep 1996 A
5558671 Yates Sep 1996 A
5569242 Lax et al. Oct 1996 A
5571147 Sluijter et al. Nov 1996 A
5573533 Strul Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5594636 Schauder Jan 1997 A
5596466 Ochi Jan 1997 A
5599344 Paterson Feb 1997 A
5599345 Edwards et al. Feb 1997 A
5605150 Radons et al. Feb 1997 A
5613966 Makower et al. Mar 1997 A
5613996 Lindsay Mar 1997 A
5625370 D'Hont Apr 1997 A
5626575 Crenner May 1997 A
5628745 Bek May 1997 A
5643330 Holsheimer et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5651780 Jackson et al. Jul 1997 A
5658322 Fleming Aug 1997 A
5660567 Nierlich et al. Aug 1997 A
5688267 Panescu et al. Nov 1997 A
5690692 Fleming Nov 1997 A
5693042 Boiarski et al. Dec 1997 A
5694304 Telefus et al. Dec 1997 A
5695494 Becker Dec 1997 A
5696351 Benn et al. Dec 1997 A
5702386 Stern et al. Dec 1997 A
5702429 King Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5712772 Telefus et al. Jan 1998 A
5713896 Nardella Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5722975 Edwards et al. Mar 1998 A
5733281 Nardella Mar 1998 A
5749869 Lindenmeier et al. May 1998 A
5749871 Hood et al. May 1998 A
5755715 Stern May 1998 A
5766165 Gentelia et al. Jun 1998 A
5769847 Panescu Jun 1998 A
5772659 Becker et al. Jun 1998 A
5792138 Shipp Aug 1998 A
5797802 Nowak Aug 1998 A
5797902 Netherly Aug 1998 A
5814092 King Sep 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5820568 Willis Oct 1998 A
5827271 Bussey et al. Oct 1998 A
5830212 Cartmell Nov 1998 A
5836943 Miller, III Nov 1998 A
5836990 Li Nov 1998 A
5846236 Lindenmeier et al. Dec 1998 A
5868737 Taylor et al. Feb 1999 A
5868739 Lindenmeier et al. Feb 1999 A
5868740 LeVeen et al. Feb 1999 A
5871481 Kannenberg et al. Feb 1999 A
5897552 Edwards et al. Apr 1999 A
5908444 Azure Jun 1999 A
5913882 King Jun 1999 A
5921982 Lesh et al. Jul 1999 A
5925070 King et al. Jul 1999 A
5931836 Hatta et al. Aug 1999 A
5938690 Law et al. Aug 1999 A
5948007 Starkebaum et al. Sep 1999 A
5951545 Schilling Sep 1999 A
5951546 Lorentzen Sep 1999 A
5954686 Garito et al. Sep 1999 A
5954717 Behl et al. Sep 1999 A
5954719 Chen et al. Sep 1999 A
5961344 Rosales et al. Oct 1999 A
5971980 Sherman Oct 1999 A
5976128 Schilling et al. Nov 1999 A
5983141 Sluijter et al. Nov 1999 A
6010499 Cobb Jan 2000 A
6014581 Whayne et al. Jan 2000 A
6033399 Gines Mar 2000 A
6044283 Fein et al. Mar 2000 A
6053910 Fleenor Apr 2000 A
6053912 Panescu et al. Apr 2000 A
6056745 Panescu et al. May 2000 A
6056746 Goble et al. May 2000 A
6063075 Mihori May 2000 A
6063078 Wittkampf May 2000 A
6068627 Orszulak et al. May 2000 A
6074386 Goble et al. Jun 2000 A
6080149 Huang et al. Jun 2000 A
6093186 Goble Jul 2000 A
RE36871 Epstein Sep 2000 E
6113591 Whayne et al. Sep 2000 A
6113596 Hooven Sep 2000 A
6123702 Swanson et al. Sep 2000 A
6132429 Baker Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6162217 Kannenberg et al. Dec 2000 A
6171304 Netherly et al. Jan 2001 B1
6203541 Keppel Mar 2001 B1
6210403 Klicek Apr 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6231569 Bek May 2001 B1
6235020 Cheng et al. May 2001 B1
6238387 Miller, III May 2001 B1
6238388 Ellman May 2001 B1
6241725 Cosman Jun 2001 B1
6245065 Panescu Jun 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6251106 Becker et al. Jun 2001 B1
6258085 Eggleston Jul 2001 B1
6261285 Novak Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6273886 Edwards Aug 2001 B1
6275786 Daners Aug 2001 B1
6293941 Strul Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6306131 Hareyama et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6309386 Bek Oct 2001 B1
6325799 Goble Dec 2001 B1
6337998 Behl et al. Jan 2002 B1
6338657 Harper et al. Jan 2002 B1
6350262 Ashley Feb 2002 B1
6358245 Edwards Mar 2002 B1
6364877 Goble et al. Apr 2002 B1
6383183 Sekino et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6402741 Keppel et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6416509 Goble et al. Jul 2002 B1
6436096 Hareyama Aug 2002 B1
6451015 Rittman, III et al. Sep 2002 B1
6458121 Rosenstock Oct 2002 B1
6464689 Qin Oct 2002 B1
6464696 Oyama Oct 2002 B1
6506189 Rittman, III et al. Jan 2003 B1
6508815 Strul Jan 2003 B1
6511476 Hareyama Jan 2003 B2
6524308 Muller et al. Feb 2003 B1
6547786 Goble Apr 2003 B1
6558376 Bishop May 2003 B2
6562037 Paton May 2003 B2
6565559 Eggleston May 2003 B2
6573248 Ramasamy et al. Jun 2003 B2
6575969 Rittman, III et al. Jun 2003 B1
6582427 Goble et al. Jun 2003 B1
6620157 Dabney et al. Sep 2003 B1
6623423 Sakurai Sep 2003 B2
6635057 Harano Oct 2003 B2
6648883 Francischelli Nov 2003 B2
6652514 Ellman Nov 2003 B2
6663623 Oyama et al. Dec 2003 B1
6663624 Edwards Dec 2003 B2
6666860 Takahashi Dec 2003 B1
6679875 Honda Jan 2004 B2
6682527 Strul Jan 2004 B2
6685700 Behl Feb 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6692489 Heim Feb 2004 B1
6712813 Ellman Mar 2004 B2
6730080 Harano May 2004 B2
6733495 Bek May 2004 B1
6733498 Paton May 2004 B2
6740079 Eggers May 2004 B1
6740085 Hareyama May 2004 B2
6783523 Qin Aug 2004 B2
6790206 Panescu Sep 2004 B2
6796981 Wham Sep 2004 B2
6824539 Novak Nov 2004 B2
6830569 Thompson Dec 2004 B2
6843789 Goble Jan 2005 B2
6849073 Hoey Feb 2005 B2
6855141 Lovewell Feb 2005 B2
6855142 Harano Feb 2005 B2
6860881 Sturm Mar 2005 B2
6864686 Novak Mar 2005 B2
6875210 Refior Apr 2005 B2
6893435 Roane May 2005 B2
7044948 Keppel May 2006 B2
7060063 Marion et al. Jun 2006 B2
7063692 Sakurai et al. Jun 2006 B2
7066933 Hagg Jun 2006 B2
20010014804 Goble et al. Aug 2001 A1
20010031962 Eggleston Oct 2001 A1
20020035363 Edwards et al. Mar 2002 A1
20020035364 Schoenman et al. Mar 2002 A1
20020068932 Edwards Jun 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020111624 Witt et al. Aug 2002 A1
20020193787 Qin Dec 2002 A1
20030004510 Wham et al. Jan 2003 A1
20030060818 Kannenberg Mar 2003 A1
20030078572 Pearson et al. Apr 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030153908 Goble Aug 2003 A1
20030163123 Goble Aug 2003 A1
20030163124 Goble Aug 2003 A1
20030171745 Francischelli Sep 2003 A1
20030199863 Swanson Oct 2003 A1
20030225401 Eggers et al. Dec 2003 A1
20040002745 Flemming Jan 2004 A1
20040015163 Buysse et al. Jan 2004 A1
20040015216 DeSisto Jan 2004 A1
20040019347 Sakurai Jan 2004 A1
20040024395 Ellman Feb 2004 A1
20040030328 Eggers Feb 2004 A1
20040030330 Brassell et al. Feb 2004 A1
20040044339 Beller Mar 2004 A1
20040049179 Francischelli Mar 2004 A1
20040054365 Goble Mar 2004 A1
20040059323 Sturm et al. Mar 2004 A1
20040068304 Paton Apr 2004 A1
20040082946 Malis Apr 2004 A1
20040095100 Thompson May 2004 A1
20040097912 Gonnering May 2004 A1
20040097914 Pantera May 2004 A1
20040097915 Refior May 2004 A1
20040116919 Heim Jun 2004 A1
20040133189 Sakural Jul 2004 A1
20040138653 Dabney et al. Jul 2004 A1
20040138654 Goble Jul 2004 A1
20040147918 Keppel Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040172016 Bek Sep 2004 A1
20040193148 Wham et al. Sep 2004 A1
20040230189 Keppel Nov 2004 A1
20040243120 Orszulak et al. Dec 2004 A1
20040260279 Goble Dec 2004 A1
20050004564 Wham Jan 2005 A1
20050004569 Witt et al. Jan 2005 A1
20050021020 Blaha et al. Jan 2005 A1
20050021022 Sturm et al. Jan 2005 A1
20050101951 Wham May 2005 A1
20050113818 Sartor May 2005 A1
20050113819 Wham May 2005 A1
20050149151 Orszulak Jul 2005 A1
20050182398 Paterson Aug 2005 A1
20050197659 Bahney Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20060025760 Podhajsky Feb 2006 A1
20060079871 Plaven et al. Apr 2006 A1
20060161148 Behnke Jul 2006 A1
Foreign Referenced Citations (78)
Number Date Country
179607 Mar 1905 DE
1099658 Feb 1961 DE
1139927 Nov 1962 DE
1439302 Jan 1969 DE
2439587 Feb 1975 DE
2455174 May 1975 DE
2407559 Aug 1975 DE
2602517 Jul 1976 DE
2504280 Aug 1976 DE
2540968 Mar 1977 DE
2820908 Nov 1978 DE
2803275 Aug 1979 DE
2823291 Nov 1979 DE
2946728 May 1981 DE
3143421 May 1982 DE
3045996 Jul 1982 DE
3120102 Dec 1982 DE
1149832 Jun 1983 DE
3510586 Oct 1986 DE
3604823 Aug 1987 DE
390937 Apr 1989 DE
3904558 Aug 1990 DE
3942998 Jul 1991 DE
4339049 May 1995 DE
19717411 Nov 1998 DE
19848540 May 2000 DE
246350 Nov 1987 EP
310431 Apr 1989 EP
325456 Jul 1989 EP
336742 Oct 1989 EP
390937 Oct 1990 EP
556705 Aug 1993 EP
0569130 Nov 1993 EP
608609 Aug 1994 EP
836868 Apr 1998 EP
0836868 Apr 1998 EP
878169 Nov 1998 EP
1293171 Mar 2003 EP
0880220 Jun 2006 EP
1275415 Oct 1961 FR
1347865 Nov 1963 FR
2313708 Dec 1976 FR
2502935 Oct 1982 FR
2517953 Jun 1983 FR
2573301 May 1986 FR
607850 Sep 1948 GB
855459 Nov 1960 GB
902775 Aug 1962 GB
2164473 Mar 1986 GB
2214430 Sep 1989 GB
2358934 Aug 2001 GB
166452 Jan 1965 SU
727201 Apr 1980 SU
WO9206642 Apr 1992 WO
WO9324066 Dec 1993 WO
WO9424949 Nov 1994 WO
WO9428809 Dec 1994 WO
WO9509577 Apr 1995 WO
WO9519148 Jul 1995 WO
WO9602180 Feb 1996 WO
WO9604860 Feb 1996 WO
WO9608794 Mar 1996 WO
WO9618349 Jun 1996 WO
WO9629946 Oct 1996 WO
WO9639914 Dec 1996 WO
WO9706739 Feb 1997 WO
WO9706740 Feb 1997 WO
WO9706855 Feb 1997 WO
WO9717029 May 1997 WO
WO0211634 Feb 2002 WO
WO0245589 Jun 2002 WO
WO0247565 Jun 2002 WO
WO02088128 Jul 2002 WO
WO03092520 Nov 2003 WO
WO2004028385 Apr 2004 WO
WO2005046496 May 2005 WO
WO2005048809 Jun 2005 WO
WO2005050151 Jun 2005 WO
Related Publications (1)
Number Date Country
20050101951 A1 May 2005 US
Provisional Applications (1)
Number Date Country
60105417 Oct 1998 US
Continuations (2)
Number Date Country
Parent 10761524 Jan 2004 US
Child 10919613 US
Parent 10073761 Feb 2002 US
Child 10761524 US
Continuation in Parts (1)
Number Date Country
Parent 09408944 Sep 1999 US
Child 10073761 US